Search results
GSK buys full rights to COVID, influenza vaccines from CureVac
Reuters via Yahoo Finance Canada· 60 minutes agoGSK said it will pay CureVac 400 million euros ($429.44 million) upfront and up to an additional...
GSK said it will pay CureVac 400 million euros ($429.44 million) upfront and up to an additional...